Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
Conclusions and Clinical Relevance This form of therapy might reduce the need for expensive monoclonal antibodies in AERD patients.
Source: World Allergy Organization Journal - Category: Allergy & Immunology Source Type: research
More News: Allergy | Allergy & Immunology | Aspirin | Asthma | Cardiology | Emergency Medicine | Gastroenterology | Heart | Respiratory Medicine | Skin